Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02830087
Other study ID # IRB00038367
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 2016
Est. completion date September 20, 2016

Study information

Verified date November 2018
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This proposed novel randomized control trial (RCT) seeks to address this gap in TKA protocol by gaining a better understanding of the relationship between tourniquet pressure and time, and intraoperative performance and post-operative outcomes. This study does not seek to answer the question of "tourniquet vs no tourniquet", but to seek a tourniquet usage that would maximize the intraoperative benefits for the surgeon and minimize the negative consequences for patient outcomes.

Specific Aim #1: enroll around 146 primary TKA patients.

Specific Aim #2: evaluate different tourniquet cuff pressures (TCP) and tourniquet times in relation to intraoperative performance.

Specific Aim #3: evaluate different TCP and tourniquet times in relation to post-operative pain and complications of short-term, intermediate, and long-term followup.

Specific Aim #4: evaluate different TCP and tourniquet times in relation to post-operative function of short-term, intermediate, and long-term followup.


Description:

The overall goal of the project is to evaluate the relationship of two variables: 1) tourniquet cuff pressure (TCP); and 2) tourniquet time (i.e. duration of inflation) during primary TKA relative to three categories of outcomes: 1) intraoperative performance; 2) post-operative pain and complications; and 3) post-operative complications.

Design

This study will use a randomized controlled trial that is double-blinded. The co-investigator, Mark Nazal, along with the principal investigator, Dr. Maxwell Langfitt, will work with the Orthopaedic Clinic Research Coordinator to recruit around 146 patients. Mark Nazal will then randomize these patients into one of six tourniquet cuff pressure (TCP) groups:

1. 220 mmHg 4) 300 mmHg

2. 250 mmHg 5) 325 mmHg

3. 275 mmHg 6) 350 mmHg

The primary TKA procedure will be performed by one of the three fellowship-trained orthopedic surgeons at Wake Forest Baptist Hospital (Dr. Maxwell Langfitt, Dr. Jason Lang, and Dr. John Shields). The orthopedic surgeon and the patient will be blinded to the TCP assignment and will not be told what tourniquet pressure is being applied. The OR nursing team will be told what the patient's assigned TCP is in order to perform the actual inflation.

Data collection will include short-term data: post-operative day 1 (POD1), post-operative day 2 (POD2), and 2-week followup; intermediate data: 6-week and 12-week followup; and long-term data: 1-year followup.

The data collection for the first category of outcomes, intraoperative performance, will begin preoperatively, with the recording of baseline characteristics: circumference of the thigh in centimeters, baseline hemoglobin levels, and thromboembolism risk evaluation.

Intraoperative data will include: the type of anesthesia, the tourniquet size in centimeters, and whether or not a drain is inserted into the joint. The time of inflation and time of deflation will be noted in order to determine the duration of tourniquet inflation.

Then preincisional blood pressure (BP) will be measured and will continue to be noted every 15 minutes. At the conclusion of the procedure the surgeon will rate intraoperative bloodlessness on a four-point scale: 1—bloodless, 2—nearly bloodless, some bleeding; 3—bloody, tourniquet is no better than not using; or 4—venous tourniquet, tourniquet is making the procedure more difficult. Intraoperative bloodlessness is being used to determine the functionality and effectiveness of the tourniquet, surgical field visualization, and surgical site dryness.

The data collection for the second category of outcomes, post-operative pain and complications, will begin on post-operative day 1 (POD1). Post-operative (post-op) pain will be assessed using a 0-10 pain rating visual analog scale for both the knee and the thigh, and will be measured at POD1, POD2, 2-week followup, 6-week followup, 12-week followup, and 1-year followup. Next, wound healing issues will be assessed at POD1, POD2, 2-week followup, 6-week followup, and 12-week followup. Wound healing issues include blisters, wound drainage, thigh bruising, significant erythema, decreased peripheral pulse, evidence of decreased distal perfusion, or decreased distal sensation.13 Estimated total blood loss will be assessed at POD2 using pre-operative Hgb-level compared to Hgb-level on post-op day 2. The patient's estimated blood volume (EBV) will be calculated using Nadler's formulas for men and women.16

Then Meunier's formula will be used to calculate estimated blood loss.16 If a drain was inserted, then the volume of drainage will be measured at POD1. Finally, aseptic loosing of the implant leading to the need for revision will be assessed at 1-year followup.

The data collection for the third category of outcomes, post-operative function, will begin at POD1. Ability to ambulate will be measured in distance by feet at POD1 and POD2. Furthermore, assessment of any use of assisted device for ambulation (wheelchair, walker, 4-point cane, and 1-point cane) will be done at POD1, POD2, 2-week followup, 6-week followup, 12-week followup and 1-year followup. Quadriceps strength and range of motion (ROM) will be recorded at 2-week followup, 6-week followup, and 12-week followup. Quadriceps strength will be measured on a 5-point scale, where 0 is no movement and 5 is full strength. ROM will be measured in degrees of motion. Next, the necessity of performing a manipulation under anesthesia (MUA) due to limited joint motion will be recorded at 6-week followup and 12-week followup. The type of PT will be recorded at 2-week followup, 6-week followup, and 12-week followup. Types of PT include out-patient PT, home health PT, PT rehabilitation, and skilled nursing facility PT.


Recruitment information / eligibility

Status Terminated
Enrollment 21
Est. completion date September 20, 2016
Est. primary completion date September 20, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. 18 - 80 years old

2. primary TKA, not revision

Exclusion Criteria:

1. systolic blood pressure (BP) = 170 mmHg

2. one-staged bilateral TKA or stages less than three months apart

3. history of peripheral vascular disease

4. history of thromboembolism

Study Design


Intervention

Procedure:
Tourniquet Cuff Pressure
Tourniquet cuff pressure is how hard the tourniquet cuff, which is placed around the patient's thigh, presses on the thigh in order to cut off blood supply to the lower leg during total knee surgery.

Locations

Country Name City State
United States Davie Medical Center Bermuda Run North Carolina
United States Wake Forest Baptist Hospital Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

References & Publications (14)

Alcelik I, Pollock RD, Sukeik M, Bettany-Saltikov J, Armstrong PM, Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2012 Mar;27(3):331-40. doi: 10.1016/j.arth.2011.04.046. Epub 2011 Sep 22. Review. — View Citation

Berry DJ, Bozic KJ. Current practice patterns in primary hip and knee arthroplasty among members of the American Association of Hip and Knee Surgeons. J Arthroplasty. 2010 Sep;25(6 Suppl):2-4. doi: 10.1016/j.arth.2010.04.033. Epub 2010 Jul 1. — View Citation

Clarke MT, Longstaff L, Edwards D, Rushton N. Tourniquet-induced wound hypoxia after total knee replacement. J Bone Joint Surg Br. 2001 Jan;83(1):40-4. — View Citation

Ejaz A, Laursen AC, Kappel A, Laursen MB, Jakobsen T, Rasmussen S, Nielsen PT. Faster recovery without the use of a tourniquet in total knee arthroplasty. Acta Orthop. 2014 Aug;85(4):422-6. doi: 10.3109/17453674.2014.931197. Epub 2014 Jun 23. — View Citation

Gibon E, Courpied JP, Hamadouche M. Total joint replacement and blood loss: what is the best equation? Int Orthop. 2013 Apr;37(4):735-9. doi: 10.1007/s00264-013-1801-0. Epub 2013 Feb 6. Review. — View Citation

Jiang FZ, Zhong HM, Hong YC, Zhao GF. Use of a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Orthop Sci. 2015 Jan;20(1):110-23. doi: 10.1007/s00776-014-0664-6. Epub 2014 Nov 6. Review. — View Citation

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5. — View Citation

Ledin H, Aspenberg P, Good L. Tourniquet use in total knee replacement does not improve fixation, but appears to reduce final range of motion. Acta Orthop. 2012 Oct;83(5):499-503. doi: 10.3109/17453674.2012.727078. Epub 2012 Sep 14. — View Citation

Li B, Wen Y, Wu H, Qian Q, Lin X, Zhao H. The effect of tourniquet use on hidden blood loss in total knee arthroplasty. Int Orthop. 2009 Oct;33(5):1263-8. doi: 10.1007/s00264-008-0647-3. Epub 2008 Aug 27. — View Citation

Liu D, Graham D, Gillies K, Gillies RM. Effects of tourniquet use on quadriceps function and pain in total knee arthroplasty. Knee Surg Relat Res. 2014 Dec;26(4):207-13. doi: 10.5792/ksrr.2014.26.4.207. Epub 2014 Dec 2. — View Citation

Olivecrona C, Ponzer S, Hamberg P, Blomfeldt R. Lower tourniquet cuff pressure reduces postoperative wound complications after total knee arthroplasty: a randomized controlled study of 164 patients. J Bone Joint Surg Am. 2012 Dec 19;94(24):2216-21. doi: 10.2106/JBJS.K.01492. — View Citation

Reilly CW, McEwen JA, Leveille L, Perdios A, Mulpuri K. Minimizing tourniquet pressure in pediatric anterior cruciate ligament reconstructive surgery: a blinded, prospective randomized controlled trial. J Pediatr Orthop. 2009 Apr-May;29(3):275-80. doi: 10.1097/BPO.0b013e31819bcd14. — View Citation

Tai TW, Lin CJ, Jou IM, Chang CW, Lai KA, Yang CY. Tourniquet use in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2011 Jul;19(7):1121-30. doi: 10.1007/s00167-010-1342-7. Epub 2010 Dec 15. Review. — View Citation

Zhang W, Li N, Chen S, Tan Y, Al-Aidaros M, Chen L. The effects of a tourniquet used in total knee arthroplasty: a meta-analysis. J Orthop Surg Res. 2014 Mar 6;9(1):13. doi: 10.1186/1749-799X-9-13. Review. — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative Pain Pain on a 11-point pain scale (0-10), with higher scores denoting worse outcomes Postoperative Day 1 through two weeks
Secondary Estimated Blood Loss Meunier's formula will be used to calculate estimated blood loss, comparing preoperative blood draw to postoperative day 2 blood draw. Postoperative Day 2
Secondary Range of Motion Measure degrees of knee flexion 2-week follow-up
Secondary Intra-operative Bloodlessness four-point scale:
1 = bloodless
2 = nearly bloodless, some bleeding
3 = bloody, tourniquet no better than not using
4 = venous tourniquet, tourniquet making things worse
Higher scores denotes worse outcome
Intraoperative
Secondary Number of Participants With Wound Healing Issues Any wound issues including blisters, wound drainage, thigh bruising, significant erythema, decreased peripheral pulse, evidence of decreased distal perfusion, or decreased distal sensation Postoperative Day 1 through 12 week follow-up
Secondary Need for Revision of Total Knee Arthroplasty Number of participants that needed a revision was necessary within one year One Year Follow-up
Secondary Ability to Ambulate Distance Walked in Feet Postoperative Day 1 through Postoperative Day 2
Secondary Quadriceps Strength Six Point Strength Scale 0 - No muscle movement
-Muscle movement, without movement at the joint
-Movement at the joint, but not against gravity
-Movement against gravity, but not against resistance
-Movement against resistance, but less than full strength
-Full Strength
Higher scores denotes better outcome
2-week follow-up through 12-week follow-up
Secondary Need for Manipulation Under Anesthesia Number of participants that needed a manipulation under anesthesia was necessary within 12 weeks 6-week follow-up through 12-week follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT04226339 - Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment N/A
Completed NCT03276143 - FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty Phase 2
Completed NCT03308071 - Hypnosis for Symptom Management in Elective Orthopedic Surgery N/A
Recruiting NCT05100706 - Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty N/A
Completed NCT04090125 - Improving Physical Activity and Gait Symmetry After Total Knee Arthroplasty N/A
Recruiting NCT04564729 - Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing N/A
Recruiting NCT03695640 - Effect of Magnesium Sulphate on Analgesia Following Knee Arthroplasty Phase 4
Recruiting NCT05877261 - Cementless Triathlon 5YR Follow-Up
Recruiting NCT05516381 - Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic Alignment N/A
Completed NCT04450485 - Surgical Approach in Fast Track Knee Arthroplasty N/A
Recruiting NCT06108063 - Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan Phase 1/Phase 2
Recruiting NCT06389435 - RObotic-assisted Versus Conventional Knee Endoprosthetic Techniques N/A
Completed NCT03898544 - Gait Kinematics After Primary Total Knee Arthroplasty (TKA) Versus Revision TKA
Completed NCT03492320 - Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
Active, not recruiting NCT02445443 - LEGION Hinge Safety and Efficacy Study
Completed NCT02186587 - iTotal Pilot Study of ConforMIS Custom Total Knee Implant N/A
Completed NCT00711711 - Manual Lymphatic Drainage Following Total Knee Arthroplasty Surgery N/A
Active, not recruiting NCT05788757 - Optetrak Knee System Post Market Clinical Follow-Up
Completed NCT03703206 - The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA) Phase 3
Completed NCT02947321 - Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial N/A

External Links